Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 2/20 | 0.42 |
| ▸ | CHUK | O15111 | 2/20 | 0.42 |
| ▸ | FBP1 | P09467 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | DBH | P09172 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | XDH | P47989 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.34 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.33 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30224871 | 0.84 | FBP1 (0.36) | IKBKBCHUKFBP1ALDH1A1MAPT | |
| SCHEMBL22658346 | 0.83 | FBP1 (0.39) | IKBKBCHUKFBP1ALDH1A1MAPT | |
| SCHEMBL18825065 | 0.79 | GPR84 (0.39) | FBP1ALDH1A1MAPT | |
| SCHEMBL1423220 | 0.77 | TDP1 (0.43) | ALDH1A1MAPTAPEX1TTRKDM4E | |
| SCHEMBL30978917 | 0.76 | HRH4 (0.44) | IKBKBCHUKFBP1ALDH1A1PLCG2 | |
| SCHEMBL2768545 | 0.76 | GRIN2D (0.49) | ALDH1A1MAPTAPEX1POLBKDM4E | |
| SCHEMBL1983087 | 0.76 | S100A4 (0.40) | FBP1ALDH1A1MAPTAPEX1KDM4E | |
| SCHEMBL24988935 | 0.76 | LMNA (0.35) | FBP1ALDH1A1MAPTXDH | |
| SCHEMBL22670427 | 0.74 | MAPT (0.42) | ALDH1A1MAPTAPEX1POLBHRH4 | |
| SCHEMBL18825089 | 0.72 | ALDH1A1 (0.46) | FBP1ALDH1A1MAPTXDHPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122155-A1 | NOVEL INDOLE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | MITOIMMUNE THERAPEUTICS INC. (KR) | 2025-04-17 | — | — | US | disclosed |
| EP-4382523-A1 | NOVEL INDOLE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | MitoImmune Therapeutics Inc. (KR) | 2024-06-12 | — | — | EP | disclosed |
| WO-2023013994-A1 | NOVEL INDOLE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | 주식회사 미토이뮨테라퓨틱스 | 2023-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122155-A1 | NOVEL INDOLE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | AIFM2, AIFM1, FECH | IKBKB 1614/4885CHUK 1564/4885FBP1 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.